GALT · Galectin Therapeutics Inc
$3.44
-0.09 (-2.55%)
At close · Aug 14
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern for a period of 12 months from the issuance date of these financial statements.”View the 10-Q filed Aug 14, 2026
Market Cap
$346.92M
Shares
100.85M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-07-06 | 279,916 | 642,774 | 922,690 | 41.3% |
| 2026-06-29 | 600,855 | 1,435,626 | 2,036,481 | 46.8% |
| 2026-06-22 | 728,839 | 5,246,289 | 5,975,128 | 41.1% |
| 2026-06-15 | 158,997 | 236,804 | 395,801 | 31.4% |
| 2026-06-08 | 221,585 | 307,404 | 528,989 | 39.5% |
| 2026-06-01 | 156,128 | 415,596 | 571,724 | 49.8% |
| 2026-05-25 | 334,328 | 717,018 | 1,051,346 | 51.4% |
| 2026-05-18 | 226,695 | 426,556 | 653,251 | 44.4% |
| 2026-05-11 | 221,148 | 686,782 | 907,930 | 46.6% |
| 2026-05-04 | 288,511 | 595,353 | 883,864 | 52.2% |
| 2026-04-27 | 150,840 | 405,378 | 556,218 | 52.3% |
| 2026-04-20 | 160,965 | 446,534 | 607,499 | 44.9% |
| 2026-04-13 | 265,677 | 472,351 | 738,028 | 42.7% |
| 2026-04-06 | 362,304 | 575,902 | 938,206 | 39.2% |
| 2026-03-30 | 134,036 | 367,460 | 501,496 | 36.2% |
| 2026-03-23 | 176,122 | 275,807 | 451,929 | 46.1% |
| 2026-03-16 | 223,125 | 358,694 | 581,819 | 40.9% |
| 2026-03-09 | 412,299 | 870,062 | 1,282,361 | 43.0% |
| 2026-03-02 | 382,868 | 349,891 | 732,759 | 39.7% |
| 2026-02-23 | 190,363 | 405,664 | 596,027 | 45.6% |
| 2026-02-16 | 92,358 | 204,335 | 296,693 | 51.4% |
| 2026-02-09 | 242,395 | 370,387 | 612,782 | 47.0% |
| 2026-02-02 | 242,356 | 335,100 | 577,456 | 38.4% |
| 2026-01-26 | 183,886 | 423,688 | 607,574 | 47.1% |
| 2026-01-19 | 277,194 | 384,916 | 662,110 | 47.3% |
| 2026-01-12 | 385,134 | 597,978 | 983,112 | 53.4% |
| 2026-01-05 | 475,810 | 1,262,157 | 1,737,967 | 52.7% |
| 2025-12-29 | 195,701 | 499,710 | 695,411 | 44.0% |
| 2025-12-22 | 306,204 | 1,061,921 | 1,368,125 | 51.2% |
| 2025-12-15 | 736,671 | 2,754,524 | 3,491,195 | 51.9% |
| 2025-12-08 | 530,995 | 1,168,960 | 1,699,955 | 45.4% |
| 2025-12-01 | 517,471 | 877,168 | 1,394,639 | 52.5% |
| 2025-11-24 | 89,987 | 215,278 | 305,265 | 40.1% |
| 2025-11-17 | 183,851 | 715,332 | 899,183 | 46.9% |
| 2025-11-10 | 372,226 | 724,896 | 1,097,122 | 50.2% |
| 2025-11-03 | 368,306 | 769,226 | 1,137,532 | 51.6% |
| 2025-10-27 | 116,985 | 1,954,844 | 2,071,829 | 78.6% |
| 2025-10-20 | 164,627 | 391,222 | 555,849 | 49.4% |
| 2025-10-13 | 237,752 | 542,793 | 780,545 | 51.4% |
| 2025-10-06 | 207,316 | 471,742 | 679,058 | 50.2% |
| 2025-09-29 | 217,709 | 449,224 | 666,933 | 55.8% |
| 2025-09-22 | 100,085 | 379,453 | 479,538 | 54.5% |
| 2025-09-15 | 137,402 | 1,007,613 | 1,145,015 | 54.4% |
| 2025-09-08 | 307,565 | 1,478,501 | 1,786,066 | 55.7% |
| 2025-09-01 | 88,114 | 387,776 | 475,890 | 56.5% |
| 2025-08-25 | 88,378 | 417,603 | 505,981 | 54.4% |
| 2025-08-18 | 95,855 | 455,749 | 551,604 | 51.9% |
Showing 1–47 of 47 weeks
Key facts
CIK
1133416
CUSIP
363225202
13F (30d)
99 filings
97 filers
Visit website
Investor relations